Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a novel drug delivery system using contrast media to deliver taxanes, effectively inhibiting restenosis after coronary stenting in a pig model. This new approach shows promise for preventing in-stent restenosis.
Area Of Science
- Cardiovascular Research
- Pharmacology
- Biomedical Engineering
Background
- Lipophilic taxanes dissolve better in contrast media than saline.
- Contrast media can outline coronary arteries, suggesting potential as a drug matrix.
- This study explores a new approach for preventing restenosis using taxane-contrast agent formulations.
Purpose Of The Study
- To evaluate a novel taxane-contrast agent formulation for preventing restenosis.
- To test the efficacy of this formulation in a coronary stenting model.
Main Methods
- In vitro: Bovine vascular smooth muscle cells (VSMCs) were incubated with iopromide-paclitaxel and iopromide-protaxel formulations.
- In vivo: 16 stents were implanted in pigs; one group received iopromide alone, the treatment group received iopromide-protaxel.
- Assessment: Quantitative angiography and histomorphometry were used to evaluate in-stent restenosis after 28 days.
Main Results
- In vitro, formulations significantly inhibited VSMC proliferation in a concentration-dependent manner.
- In vivo, the treatment group showed a 34% reduction in neointimal area compared to controls.
- No systemic toxicity was observed at the tested protaxel dose.
Conclusions
- A contrast agent serves as an effective solvent for taxanes, creating a novel drug delivery system.
- This taxane-contrast agent formulation demonstrates efficacy in inhibiting in-stent restenosis.
- This approach shows potential as a new strategy for preventing restenosis in coronary stenting.